Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Age-related changes in serum levels of insulin-like growth factor-II and its binding proteins correlate with calcaneal bone mineral density among post-menopausal South-Indian women.

Sittadjody S, Ilangovan R, Thangasamy T, Vignesh RC, Veni S, Bertoni AG, Srinivasan S, Subramanian C, Srinivasan N.

Clin Chim Acta. 2012 Dec 24;414:281-8. doi: 10.1016/j.cca.2012.09.030. Epub 2012 Oct 3.

PMID:
23041218
2.

A potentially deleterious role of IGFBP-2 on bone density in aging men and women.

Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ 3rd, Khosla S.

J Bone Miner Res. 2004 Jul;19(7):1075-83. Epub 2004 Mar 22.

3.

High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.

Amin S, Riggs BL, Melton LJ 3rd, Achenbach SJ, Atkinson EJ, Khosla S.

J Bone Miner Res. 2007 Jun;22(6):799-807.

4.
6.

Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.

Boonen S, Mohan S, Dequeker J, Aerssens J, Vanderschueren D, Verbeke G, Broos P, Bouillon R, Baylink DJ.

J Bone Miner Res. 1999 Dec;14(12):2150-8.

7.

Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.

Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.

Gynecol Endocrinol. 2005 Mar;20(3):176-82.

PMID:
16019358
8.

Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, sex steroids, osteocalcin and bone mineral density in male and female rats.

Fukuda R, Usuki S, Mukai N, Amagai H, Hayashi K, Takamatsu K.

Gynecol Endocrinol. 1998 Oct;12(5):297-305.

PMID:
9859021
9.

Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.

Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G.

Horm Res. 2006;66(4):162-8. Epub 2006 Jun 23.

PMID:
16804317
10.

Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.

Krassas GE, Papadopoulou P, Koliakos G, Konstantinidis T, Kalothetou K.

Arch Androl. 2003 May-Jun;49(3):191-9.

PMID:
12746097
11.

Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.

Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.

J Bone Miner Res. 1998 May;13(5):891-9.

13.

Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.

Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, Baylink DJ, Mohan S, Chihara K, Sugimoto T.

Calcif Tissue Int. 2006 Jan;78(1):18-24. Epub 2006 Jan 6.

14.

Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.

Diabetes Metab Res Rev. 1999 Sep-Oct;15(5):314-22.

PMID:
10585616
15.

The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.

Cotterill AM, Mendel P, Holly JM, Timmins AG, Camacho-Hübner C, Hughes SC, Ross RM, Blum WF, Langford RM.

Clin Endocrinol (Oxf). 1996 Jan;44(1):91-101.

PMID:
8706300
16.

Influence of treatment with onapristone on the IGF-system in breast cancer patients.

Helle SI, Jonat W, Giurescu M, Ekse D, Holly JM, Lønning PE.

J Steroid Biochem Mol Biol. 1998 Aug;66(3):159-63.

PMID:
9719450
17.

Effects of growth hormone treatment on serum levels of insulin-like growth factors (IGFs) and IGF binding proteins 1-4 in postmenopausal women.

Kassem M, Brixen K, Mosekilde L, Blum WF, Flyvbjerg A.

Clin Endocrinol (Oxf). 1998 Dec;49(6):747-56.

PMID:
10209562
18.

Insulin-like growth factor binding proteins 4 and 5 and bone mineral density in elderly men and women.

Karasik D, Rosen CJ, Hannan MT, Broe KE, Dawson-Hughes B, Gagnon DR, Wilson PW, Visser M, Langlois JA, Mohan S, Kiel DP.

Calcif Tissue Int. 2002 Oct;71(4):323-8. Epub 2002 Sep 4.

PMID:
12202958
19.

Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis.

Toussirot E, Nguyen NU, Dumoulin G, Regnard J, Wendling D.

Br J Rheumatol. 1998 Nov;37(11):1172-6.

PMID:
9851264
20.

Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.

Lakatos P, Foldes J, Nagy Z, Takacs I, Speer G, Horvath C, Mohan S, Baylink DJ, Stern PH.

Thyroid. 2000 May;10(5):417-23.

PMID:
10884189

Supplemental Content

Support Center